Screener
ARS Pharmaceuticals, Inc. SPRY Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Property, plant and equipment, net | 2,285 | 2,465 |
| Intangible assets, net | 14,176 | 14,452 |
| Other assets | 2,653 | 2,786 |
| Total assets | $287,571 | $327,652 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities (including related party amounts of $1,431 and $1,624, respectively) | $48,263 | $37,948 |
| Contract liability, current | 757 | 609 |
Item 1. Financial Statements
FAQ
- What is ARS Pharmaceuticals, Inc.'s total assets?
- ARS Pharmaceuticals, Inc. (SPRY) reported total assets of $287.57M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s total assets changed year-over-year?
- ARS Pharmaceuticals, Inc.'s total assets decreased by 12.1% year-over-year, from $327.32M to $287.57M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s total assets has grown at a -3.7% compound annual growth rate (CAGR), from $394.8M to $327.65M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about ARS Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude